Q4 2023 Holdings
Filed 2024-01-30 | 35 holdings | $132.0M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-02-02) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ishares TR(SGOV) | 0-3 MNTH TREASRY | 46436E718 | $27.1M | 270,000 | 20.5% |
| Spdr SER TR(BIL) | BLOOMBERG 1-3 MO | 78468R663 | $18.3M | 200,000 | 13.8% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $16.7M | 5,462,079 | 12.6% |
| Cyteir Therapeutics Inc | COM | 23284P103 | $9.9M | 3,250,008 | 7.5% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $6.4M | 245,500 | 4.9% |
| Eliem Therapeutics Inc(CLYM) | COM | 28658R106 | $5.9M | 2,180,000 | 4.5% |
| Avrobio Inc | COM | 05455M100 | $5.4M | 4,001,627 | 4.1% |
| Theseus Pharmaceuticals IncA | COM | 88369M101 | $4.5M | 1,108,320 | 3.4% |
| Athira Pharma Inc | COM | 04746L104 | $3.5M | 1,454,362 | 2.7% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $3.4M | 4,554,252 | 2.6% |
| Abercrombie & Fitch Co(ANF) | CL A | 002896207 | $3.0M | 900 | 2.3% |
| Abercrombie & Fitch Co(ANF)PutA | CL A | 002896207 | $3.0M | 900 | 2.3% |
| Oramed Pharmaceuticals Inc(ORMP) | COM NEW | 68403P203 | $2.9M | 1,261,559 | 2.2% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $2.7M | 1,029,478 | 2.1% |
| Connect Biopharma Hldgs LTD | ADS | 207523101 | $2.4M | 2,061,438 | 1.8% |
| Reneo Pharmaceuticals Inc(RPHM) | COM | 75974E103 | $2.1M | 1,314,229 | 1.6% |
| Astrotech Corp(ASTC) | COM | 046484309 | $1.9M | 220,410 | 1.4% |
| Rain Oncology Inc | COM | 75082Q105 | $1.6M | 1,349,007 | 1.2% |
| Forte Biosciences Inc(TOCAEUR) | COM | 34962G109 | $1.4M | 1,761,702 | 1.1% |
| Verrica Pharmaceuticals Inc | COM | 92511W108 | $1.3M | 180,000 | 1.0% |
| Wingstop Inc(WING)PutA | COM | 974155103 | $1.2M | 900 | 0.9% |
| Wingstop Inc(WING) | COM | 974155103 | $1.2M | 900 | 0.9% |
| Arca Biopharma Inc(ABIOEUR) | COM | 00211Y506 | $1.2M | 706,930 | 0.9% |
| Graphite BIO Inc(GRPH)A | COM | 38870X104 | $1.2M | 447,416 | 0.9% |
| Kinnate Biopharma IncA | COM | 49705R105 | $1.1M | 468,210 | 0.8% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $771.0K | 150,000 | 0.6% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $738.7K | 442,352 | 0.6% |
| Lisata Therapeutics Inc(LSTA) | COM | 128058302 | $736.7K | 269,839 | 0.6% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $692.0K | 50,000 | 0.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $685.8K | 653,107 | 0.5% |
| Invesco QQQ TR(QQQ) | UNIT SER 1 | 46090E103 | $661.2K | 300 | 0.5% |
| Invesco QQQ TR(QQQ)PutA | UNIT SER 1 | 46090E103 | $661.2K | 300 | 0.5% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $478.0K | 24,666 | 0.4% |
| Build-A-Bear Workshop Inc(BBW)PutA | COM | 120076104 | $465.0K | 1,500 | 0.4% |
| Homology Medicines Inc | COM | 438083107 | $454.9K | 748,108 | 0.3% |
| Calcimedica Inc(CALC) | COM NEW | 38942Q202 | $415.9K | 145,424 | 0.3% |
| Build-A-Bear Workshop Inc(BBW) | COM | 120076104 | $401.3K | 1,000 | 0.3% |
| Nextcure Inc | COM | 65343E108 | $349.4K | 306,465 | 0.3% |
| Talis Biomedical Corp(TLIS) | COM NEW | 87424L207 | $318.4K | 42,743 | 0.2% |